Therapeutic uses of a – adrenoreceptor blockers include all of the following except-
The correct answer is probably something not commonly associated. For example, maybe they're not used in heart failure? Because beta-blockers are more typical there. Or perhaps in peripheral vascular disease? Wait, phentolamine is an alpha-blocker used for Raynaud's. So that's a use. So if an option says "Peripheral artery disease" or "Heart failure," that might be the exception. Let me check the options again, but since they are missing, I'll proceed with the assumption that the incorrect use is heart failure or something similar.
For the explanation, the core concept is that alpha-blockers block alpha-adrenergic receptors, leading to vasodilation. Their uses include hypertension, BPH, pheochromocytoma, and Raynaud's. The exception would be a condition where alpha-blockers aren't indicated. For example, heart failure management typically uses beta-blockers and ACE inhibitors, not alpha-blockers. So if one of the options is heart failure, that's the incorrect one. Then, I need to explain why each wrong option is incorrect. For example, if an option says "Heart failure," explain that alpha-blockers aren't used there because they can worsen heart failure by causing vasodilation without improving cardiac output.
Clinical pearl: Remember that alpha-blockers are not first-line for hypertension in heart failure. High-yield fact: Phenoxybenzamine and phentolamine are used in pheochromocytoma. The correct answer would be the one that's not a standard use. Let me structure the explanation accordingly, making sure each section is covered concisely.
**Core Concept**
Alpha-adrenoreceptor blockers inhibit sympathetic vasoconstriction by blocking Ξ±β and Ξ±β receptors, reducing peripheral resistance. They are used in hypertension, pheochromocytoma, benign prostatic hyperplasia (BPH), and Raynaudβs phenomenon.
**Why the Correct Answer is Right**
The exception is **heart failure**. Alpha-blockers are contraindicated in heart failure due to unopposed Ξ²-adrenergic stimulation, which increases myocardial oxygen demand and worsens cardiac output. Their vasodilatory effects also reduce venous return, exacerbating hypotension.
**Why Each Wrong Option is Incorrect**
**Option A:** *Hypertension* β Alpha-blockers reduce blood pressure by dilating arterioles.
**Option B:** *Benign prostatic hyperplasia* β Blocks Ξ±β receptors in the prostate, easing urinary flow.
**Option C:** *Pheochromocytoma* β Phenoxybenzamine blocks excessive catecholamine release, preventing hypertensive crises.
**Clinical Pearl / High-Yield Fact**
Avoid alpha-blockers in heart failure; they worsen outcomes. Remember: **"Alpha-blockers